Abstract
Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have